Stefan Oschmann

E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany.

Oschmann Comfortbetten GmbH engages in the manufacturing of beds. The company was founded by Stefan Oschmann and is headquartered in Coburg, Germany.

Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany.

Springer Nature Deutschland GmbH publishes scientific books, periodicals, and journals that focus on scientific and technical information. It also offers business services, seminars, trade fairs, conferences, as well as online publishing. The company was founded by Julius Springer on May 10, 1842 and is headquartered in Berlin, Germany.

Springer Nature AG & Co. KGaA engages in the publishing business. Its activities also include the development, acquisition, and marketing of information systems and related products. In addition, the firm trades in licenses as well as other rights to media and information systems. The company is headquartered in Berlin, Germany.

Part of Merck KGaA, Millipore SpA is an Italian company that provides industrial instruments for measurement. The company is based in Vimodrone, Italy. The CEO of the company is Stefan Oschmann.

Malteser Deutschland gGmbH engages in the management and operation of medical and nursing care institutions. These include hospitals, senior homes, nursing facilities, and stationary hospices. The company was founded on May 3, 1999 and is headquartered in Cologne, Germany.

Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023.

Stämm Biotech designs novel bio production system that leverages microfluidics and electroporation. It helps to solve the main constraint of the biotech industries. The company was founded by Federico D'Alvia Vegh and Juan Francisco Llamazares Vegh in 2014 and is headquartered in San Francisco, CA.